In the present study we investigated the expression of p53 isoforms by immunohistochemistry (IHC), using a suite of C- and N-terminal p53 isoform-specific antibodies in a retrospective melanoma cohort and evaluated their prognostic biomarker potential. The gene discussed is TP53; the disease is melanoma.